Blog

Joshua Muia: Two posters on the enzyme ADAMTS13 being a biomarker in sepsis at ISTH

Photo from Joshua Muia/LinkedIn

Jun 30, 2024, 12:42

Joshua Muia: Two posters on the enzyme ADAMTS13 being a biomarker in sepsis at ISTH

Joshua Muia, Associate Investigator at Versiti Blood Research Institute, posted on LinkedIn:

“I am thrilled to attend the 2024 International Society on Thrombosis and Haemostasis (ISTH) Congress ISTH2024 inBangkok, Thailand. My student Frida Miranda (Oklahoma State University, Center for Health Sciences) and I presented two posters on a newly developed multiplex assay of the enzyme ADAMTS13 and ADAMTS13 being a biomarker in Sepsis. Frida’s Outstanding Abstract was recognized with a Career Travel Award and ISTH 2021 Philadelphia Congress Local Organizing Committee Legacy Fund Award.”

Source: Joshua Muia/LinkedIn

ADAMTS13 cancer Career Travel Award International Society on Thrombosis and Haemostasis ISTH ISTH 2021 Philadelphia Congress Local Organizing Committee Legacy Fund Award Joshua Muia OncoDaily Oncology sepsis

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer